Rezolute Reports Positive Preliminary Phase 3 Results for Tumor HI
Thirteen participants met the study’s response criterion, while three remain in the pivotal phase ahead of final results expected in December.
Makkler Newsroom · Nov 13, 02:46 PM · 1 min read
